Kazia Therapeutics Ltd (KZIA)
0.272
-0.01
(-3.72%)
USD |
NASDAQ |
May 03, 16:00
0.277
0.00 (0.00%)
After-Hours: 20:00
Kazia Therapeutics Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
June 30, 2020 | 0.00 |
December 31, 2019 | 1.651M |
June 30, 2019 | 1.651M |
December 31, 2018 | 0.1205M |
June 30, 2018 | 0.1134M |
December 31, 2017 | -0.0086M |
June 30, 2017 | -5.336M |
December 31, 2016 | -5.312M |
June 30, 2016 | -0.3752M |
December 31, 2015 | -0.4641M |
June 30, 2015 | -0.0695M |
December 31, 2014 | 0.0457M |
Date | Value |
---|---|
June 30, 2014 | -0.0248M |
December 31, 2013 | -0.0837M |
June 30, 2013 | 0.179M |
December 31, 2012 | 0.2048M |
June 30, 2012 | 8.088M |
December 31, 2011 | 7.931M |
June 30, 2011 | 0.2736M |
December 31, 2010 | 0.4114M |
June 30, 2010 | -0.009M |
December 31, 2009 | -0.0306M |
June 30, 2009 | -0.0626M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
Jun 2020
1.651M
Maximum
Jun 2019
1.100M
Average
1.651M
Median
Jun 2019
Cash from Investing (TTM) Benchmarks
Immutep Ltd | -0.0131M |
Opthea Ltd | -0.0192M |
Alterity Therapeutics Ltd | -0.0044M |
Mesoblast Ltd | -0.194M |
Immuron Ltd | 0.0881M |